Brain (and spinal cord) tumours
Open
Phase 1
This study is looking at a targeted treatment called 123I-ATT001 for a type of brain tumour called that has come back after treatment.
Recruitment start: 4 July 2024
Recruitment end: 30 October 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Paul Mulholland
Theragnostics Limited, an Ariceum company
Last reviewed: 28 January 2025
CRUK internal database number: 19962
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
